Opdualag ইউরোপীয় ইউনিয়ন - রোমানীয় - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanomul - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Sotyktu ইউরোপীয় ইউনিয়ন - রোমানীয় - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - psoriazis - imunosupresoare - treatment of moderate-to-severe plaque psoriasis in adults.

HYDREA 500 mg রুমানিয়া - রোমানীয় - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

hydrea 500 mg

latina pharma s.p.a. - italia - hydroxycarbamidum - caps. - 500mg - alte antineoplazice alte antineoplazice